Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon.
Cancers
Incorvaia, Lorena L; Fanale, Daniele D; Vincenzi, Bruno B; De Luca, Ida I; Bartolotta, Tommaso Vincenzo TV; Cannella, Roberto R; Pantuso, Gianni G; Cabibi, Daniela D; Russo, Antonio A; Bazan, Viviana V; Badalamenti, Giuseppe G
Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells.
Scientific Reports
Rausch, Jessica L JL; Ali, Areej A AA; Lee, Donna M DM; Gebreyohannes, Yemarshet K YK; Mehalek, Keith R KR; Agha, Aya A; Patil, Sneha S SS; Tolstov, Yanis Y; Wellens, Jasmien J; Dhillon, Harbir S HS; Makielski, Kathleen R KR; Debiec-Rychter, Maria M; Schöffski, Patrick P; Wozniak, Agnieszka A; Duensing, Anette A
Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study.
Translational Oncology
Kwon, Dohee D; Kim, Binnari B; Shin, Hyeong Chan HC; Kim, Eun Ji EJ; Ha, Sang Yun SY; Jang, Kee-Taek KT; Kim, Seung Tae ST; Lee, Jeeyun J; Kang, Won Ki WK; Park, Joon Oh JO; Kim, Kyoung-Mee KM
Pan-urologic cancer genomic subtypes that transcend tissue of origin.
Nature Communications
Chen, Fengju F; Zhang, Yiqun Y; Bossé, Dominick D; Lalani, Aly-Khan A AA; Hakimi, A Ari AA; Hsieh, James J JJ; Choueiri, Toni K TK; Gibbons, Don L DL; Ittmann, Michael M; Creighton, Chad J CJ
Publication Date: 2017-08-04
Variant appearance in text: KIT: 1678_1728del; V560_L576del
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models.
Molecular Cancer Therapeutics
Smyth, Tomoko T; Van Looy, Thomas T; Curry, Jayne E JE; Rodriguez-Lopez, Ana M AM; Wozniak, Agnieszka A; Zhu, Meijun M; Donsky, Rachel R; Morgan, Jennifer G JG; Mayeda, Mark M; Fletcher, Jonathan A JA; Schöffski, Patrick P; Lyons, John J; Thompson, Neil T NT; Wallis, Nicola G NG